[
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals' (NASDAQ:REGN) investors will be pleased with their decent 89% return over the last five years",
    "summary": "The last three months have been tough on Regeneron Pharmaceuticals, Inc. ( NASDAQ:REGN ) shareholders, who have seen...",
    "url": "https://finnhub.io/api/news?id=5dcf59bb5075ca3c57894c4c707286d70ad93c70f2175bc5bac0c2a80dd1d5f1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735646425,
      "headline": "Regeneron Pharmaceuticals' (NASDAQ:REGN) investors will be pleased with their decent 89% return over the last five years",
      "id": 132215831,
      "image": "https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "The last three months have been tough on Regeneron Pharmaceuticals, Inc. ( NASDAQ:REGN ) shareholders, who have seen...",
      "url": "https://finnhub.io/api/news?id=5dcf59bb5075ca3c57894c4c707286d70ad93c70f2175bc5bac0c2a80dd1d5f1"
    }
  }
]